Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial
2011

Induction of Labour vs. Expectant Monitoring for Gestational Hypertension

Sample size: 680 publication 10 minutes Evidence: moderate

Author Information

Author(s): Josje Langenveld, Kim Broekhuijsen, Gert-Jan van Baaren, Maria G van Pampus, Anton H van Kaam, Henk Groen, Martina Porath, Martijn A Oudijk, Kitty W Bloemenkamp, Christianne J de Groot, Erik van Beek, Marloes E van Huizen, Herman P Oosterbaan, Christine Willekes, Ella J Wijnen-Duvekot, Maureen T M Franssen, Denise A M Perquin, Jan M J Sporken, Mallory D Woiski, Henk A Bremer, Dimitri N M Papatsonis, Jozien T J Brons, Mesrure Kaplan, Bas W A Nij Bijvanck, Ben-Willen J Mol

Primary Institution: Maastricht University Medical Centre

Hypothesis

Induction of labour will reduce maternal morbidity and mortality, but at the cost of increased neonatal morbidity.

Conclusion

The trial will provide evidence on whether induction of labour in women with hypertensive disorders in the late pre-term period is effective in preventing severe maternal complications without compromising neonatal health.

Supporting Evidence

  • Induction of labour reduces the risk of severe maternal complications.
  • Late pre-term infants have higher morbidity compared to term infants.
  • The study aims to clarify the management of hypertensive disorders in late pre-term pregnancies.

Takeaway

This study is trying to find out if inducing labor early for pregnant women with high blood pressure is better than waiting, to keep both moms and babies healthy.

Methodology

A multicentre, open-label randomised controlled trial comparing induction of labour with expectant monitoring in women with gestational hypertension or mild pre-eclampsia at 34-37 weeks of gestation.

Potential Biases

Potential bias due to the open-label design and the inability to blind participants and healthcare providers.

Limitations

The study may not account for all variations in clinical practice and patient demographics across different centers.

Participant Demographics

Pregnant women aged 18 and older with gestational hypertension, mild pre-eclampsia, or deteriorating chronic hypertension between 34+0 and 36+6 weeks of gestation.

Statistical Information

P-Value

0.05

Confidence Interval

95% CI 0.55 - 1.04

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2393-11-50

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication